Skip to content

KURA · Kura Oncology, Inc.

Healthcare · −6.4% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 9 feeds behind: FDA drug approvals, 3 days, and 8 more · Every feed →

On this page

The market view

Price chart

The interactive KURA chart (by TradingView) loads here.

Our take

2 rules fired on KURA

In short: none of these rules has solid or some evidence yet, so they show no clear lean on KURA.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

The 0–100 score for KURA, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on KURA, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of KURA. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 22, 2026–Oct 19, 2026 · UTC dates · today is excluded

Insider sales

Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual.

Latest 28 days
6
Earlier median
0
Earlier range
0–2
Distinct filers per 28 daysScale: 0–6
Oct 21, 2025Oct 19, 2026
Earlier periodsLatest 28 daysEarlier median 0Limited or missing history

Who appears in the latest period?

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Jun 22, 2026. Newest disclosure across this feed: Oct 16, 2026.

Earlier periods in the comparison: 3. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–1.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 21, 2025–Nov 17, 2025—Unavailable
Nov 18, 2025–Dec 15, 2025—Unavailable
Dec 16, 2025–Jan 12, 2026—Unavailable
Jan 13, 2026–Feb 9, 2026—Unavailable
Feb 10, 2026–Mar 9, 2026—Unavailable
Mar 10, 2026–Apr 6, 2026—Unavailable
Apr 7, 2026–May 4, 2026—Unavailable
May 5, 2026–Jun 1, 2026—Unavailable
Jun 2, 2026–Jun 29, 20260Partial; excluded
Jun 30, 2026–Jul 27, 20260Within stored history
Jul 28, 2026–Aug 24, 20261Within stored history
Aug 25, 2026–Sep 21, 20260Within stored history
Sep 22, 2026–Oct 19, 2026Latest period0Within stored history
Insider sales · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–2.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 21, 2025–Nov 17, 2025—Unavailable
Nov 18, 2025–Dec 15, 2025—Unavailable
Dec 16, 2025–Jan 12, 2026—Unavailable
Jan 13, 2026–Feb 9, 2026—Unavailable
Feb 10, 2026–Mar 9, 2026—Unavailable
Mar 10, 2026–Apr 6, 2026—Unavailable
Apr 7, 2026–May 4, 2026—Unavailable
May 5, 2026–Jun 1, 2026—Unavailable
Jun 2, 2026–Jun 29, 20261Partial; excluded
Jun 30, 2026–Jul 27, 20260Within stored history
Jul 28, 2026–Aug 24, 20262Within stored history
Aug 25, 2026–Sep 21, 20260Within stored history
Sep 22, 2026–Oct 19, 2026Latest period6Within stored history
Congress purchases · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 21, 2025–Nov 17, 2025—Unavailable
Nov 18, 2025–Dec 15, 2025—Unavailable
Dec 16, 2025–Jan 12, 2026—Unavailable
Jan 13, 2026–Feb 9, 2026—Unavailable
Feb 10, 2026–Mar 9, 2026—Unavailable
Mar 10, 2026–Apr 6, 2026—Unavailable
Apr 7, 2026–May 4, 2026—Unavailable
May 5, 2026–Jun 1, 2026—Unavailable
Jun 2, 2026–Jun 29, 2026—Unavailable
Jun 30, 2026–Jul 27, 2026—Unavailable
Jul 28, 2026–Aug 24, 2026—Unavailable
Aug 25, 2026–Sep 21, 2026—Unavailable
Sep 22, 2026–Oct 19, 2026Latest period—Unavailable
Congress sales · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 21, 2025–Nov 17, 2025—Unavailable
Nov 18, 2025–Dec 15, 2025—Unavailable
Dec 16, 2025–Jan 12, 2026—Unavailable
Jan 13, 2026–Feb 9, 2026—Unavailable
Feb 10, 2026–Mar 9, 2026—Unavailable
Mar 10, 2026–Apr 6, 2026—Unavailable
Apr 7, 2026–May 4, 2026—Unavailable
May 5, 2026–Jun 1, 2026—Unavailable
Jun 2, 2026–Jun 29, 2026—Unavailable
Jun 30, 2026–Jul 27, 2026—Unavailable
Jul 28, 2026–Aug 24, 2026—Unavailable
Aug 25, 2026–Sep 21, 2026—Unavailable
Sep 22, 2026–Oct 19, 2026Latest period—Unavailable
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

FDA & trials

All 26 records in this snapshot
  1. Disclosed
    Brian T. Powl · Sale

    Transaction dated Sep 28, 2026

  2. Disclosed
    Brian T. Powl · Sale

    Transaction dated Sep 28, 2026

  3. Disclosed
    Brian T. Powl · Sale

    Transaction dated Sep 29, 2026

  4. Disclosed
    Kathleen Ford · Sale

    Transaction dated Sep 29, 2026

  5. Disclosed
    Kathleen Ford · Sale

    Transaction dated Sep 28, 2026

  6. Disclosed
    Mollie Leoni · Sale

    Transaction dated Sep 28, 2026

  7. Disclosed
    Mollie Leoni · Sale

    Transaction dated Sep 29, 2026

  8. Filed
  9. Filed
  10. Filed
  11. Disclosed
    Teresa Brophy Bair · Sale

    Transaction dated Sep 28, 2026

  12. Disclosed
    Thomas James Doyle · Sale

    Transaction dated Sep 28, 2026

  13. Filed
  14. Filed
  15. Disclosed
    Francis Burrows · Sale

    Transaction dated Sep 24, 2026

  16. Filed
  17. Record date
  18. Filed
  19. Disclosed
    Brian T. Powl · Sale

    Transaction dated Aug 21, 2026

  20. Disclosed
    Troy Edward Wilson · Purchase

    Transaction dated Aug 24, 2026

  21. Disclosed
    Teresa Brophy Bair · Sale

    Transaction dated Aug 19, 2026

  22. Disclosed
    Troy Edward Wilson · Purchase

    Transaction dated Aug 17, 2026

  23. Filed
  24. Filed
  25. Filed
  26. Disclosed
    Mollie Leoni · Sale

    Transaction dated Jun 18, 2026

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on KURA disclosed in the last 90 days.

See every Congress trade on KURA →

Company insiders

2 buys · 8 sells (14 filed lots) · $1.7M sold · $2.4M bought

  1. ▼ SELLBrian T. Powl Chief Commercial OfficerKURA Kura Oncology, Inc.$84.5Kdisclosed Sep 29 · filed 1 day after the trade
  2. ▼ SELLBrian T. Powl Chief Commercial OfficerKURA Kura Oncology, Inc.$94.7Kdisclosed Sep 29 · filed 1 day after the trade
  3. ▼ SELLTeresa Brophy Bair Chief Legal OfficerKURA Kura Oncology, Inc.$88.6Kdisclosed Sep 29 · filed 1 day after the trade
  4. ▼ SELLBrian T. Powl Chief Commercial OfficerKURA Kura Oncology, Inc.$166Kdisclosed Sep 29 · filed the same day
  5. ▼ SELLThomas James Doyle SVP, Finance & AccountingKURA Kura Oncology, Inc.$48.4Kdisclosed Sep 29 · filed 1 day after the trade
  6. ▼ SELLKathleen Ford Chief Operating OfficerKURA Kura Oncology, Inc.$39.4Kdisclosed Sep 29 · filed the same day
  7. ▼ SELLKathleen Ford Chief Operating OfficerKURA Kura Oncology, Inc.$72.5Kdisclosed Sep 29 · filed 1 day after the trade
  8. ▼ SELLMollie Leoni Chief Medical OfficerKURA Kura Oncology, Inc.$131Kdisclosed Sep 29 · filed 1 day after the trade
  9. ▼ SELLMollie Leoni Chief Medical OfficerKURA Kura Oncology, Inc.$310Kdisclosed Sep 29 · filed the same day
  10. ▼ SELLFrancis Burrows Chief Scientific OfficerKURA Kura Oncology, Inc.$225Kdisclosed Sep 25 · filed 1 day after the trade
See every insider trade on KURA →

Filings & events

Company filings (8-K) 59

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Other events · item 8.0112
  • Quarterly or yearly results · item 2.0212
  • Directors or officers joined, left or got new pay · item 5.025
  • Shareholder vote results · item 5.073
  • Signed a major agreement · item 1.013
  • Changed its charter or bylaws · item 5.031

Filing red flags 21

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

Planned insider sales (Form 144) 48

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

12 in the last 90 days · 48 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 5

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 0 filings
  • 13G, just holds: 5 filings

Filed by Vanguard Capital Management LLC · State Street Corp · Armistice Capital, LLC · Biotechnology Value Fund L P

Biggest named funds (13F)

The largest KURA holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on KURA

  1. ▼ SELLBrian T. Powl Chief Commercial OfficerKURA Kura Oncology, Inc.$84.5Kdisclosed Sep 29 · filed 1 day after the trade
  2. ▼ SELLBrian T. Powl Chief Commercial OfficerKURA Kura Oncology, Inc.$94.7Kdisclosed Sep 29 · filed 1 day after the trade
  3. ▼ SELLTeresa Brophy Bair Chief Legal OfficerKURA Kura Oncology, Inc.$88.6Kdisclosed Sep 29 · filed 1 day after the trade
  4. ▼ SELLBrian T. Powl Chief Commercial OfficerKURA Kura Oncology, Inc.$166Kdisclosed Sep 29 · filed the same day
  5. ▼ SELLThomas James Doyle SVP, Finance & AccountingKURA Kura Oncology, Inc.$48.4Kdisclosed Sep 29 · filed 1 day after the trade
  6. ▼ SELLKathleen Ford Chief Operating OfficerKURA Kura Oncology, Inc.$39.4Kdisclosed Sep 29 · filed the same day
  7. ▼ SELLKathleen Ford Chief Operating OfficerKURA Kura Oncology, Inc.$72.5Kdisclosed Sep 29 · filed 1 day after the trade
  8. ▼ SELLMollie Leoni Chief Medical OfficerKURA Kura Oncology, Inc.$131Kdisclosed Sep 29 · filed 1 day after the trade
  9. ▼ SELLMollie Leoni Chief Medical OfficerKURA Kura Oncology, Inc.$310Kdisclosed Sep 29 · filed the same day
  10. ▼ SELLFrancis Burrows Chief Scientific OfficerKURA Kura Oncology, Inc.$225Kdisclosed Sep 25 · filed 1 day after the trade
  11. ▼ SELLBrian T. Powl Chief Commercial OfficerKURA Kura Oncology, Inc.$51.7Kdisclosed Aug 24 · filed 3 days after the trade
  12. ▲ BUYTroy Edward Wilson President and CEOKURA Kura Oncology, Inc.$1.2Mdisclosed Aug 24 · filed the same day
  13. ▼ SELLTeresa Brophy Bair Chief Legal OfficerKURA Kura Oncology, Inc.$398Kdisclosed Aug 21 · filed 2 days after the trade
  14. ▲ BUYTroy Edward Wilson President and CEOKURA Kura Oncology, Inc.$1.1Mdisclosed Aug 17 · filed the same day
  15. ▼ SELLMollie Leoni Chief Medical OfficerKURA Kura Oncology, Inc.$834Kdisclosed Jun 22 · filed 4 days after the trade
See the trades on KURA in the feed →
People & votes

Which members of Congress traded KURA, sponsored bills that touch it and voted on them — opens here.